Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...
The FDA has finally approved the first generic of GlaxoSmithKline’s Advair blockbuster respiratory ... fluticasone propionate 250 mcg/salmeterol 50 mcg and fluticasone propionate 500 mcg ...
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretideâ„¢ or Advair ®) is low. However, when asthma control deteriorates ...
While Sandoz has emerged as the front-runner to get a generic version of GlaxoSmithKline’s respiratory blockbuster Advair to the US market, rival Hikma has not given up despite a major setback.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback